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*Author for correspondenceWe have raised a monoclonal antibody (mAb) (HFD9) that
detects a 28 kDa protein (p28) enriched in the Golgi
membrane. p28 was localized to the perinuclear Golgi
region in all cell lines thus far examined. Its Golgi local-
ization was confirmed by its colocalization with Golgi
markers using indirect immunofluorescence microscopy.
Immunogold labelling demonstrates that the majority of
p28 was localized on the cis-Golgi and its associated struc-
tures. Two independent experiments demonstrate that the
p28 epitope recognized by mAb HFD9 is exposed to the
cytosol. Extraction of Golgi membranes with a variety of
reagents revealed that p28 behaves like an integral
membrane protein. mAb HFD9 thus defines a novel 28 kDa
integral membrane protein on the cis-Golgi. To our
knowledge, p28 represents the first integral membrane
protein of the Golgi system identified via the antibody
approach whose epitope is cytoplasmically-oriented and
highly-conserved. Monoclonal antibody HFD9 will thus
provide a useful tool for further studies on the cis side of
the Golgi, which is not well characterised due to the lack
of good markers.
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SUMMARYINTRODUCTION
Proteins destined for the exocytotic (secretory) pathway of
eukaryotic cells are initially targeted to the endoplasmic
reticulum (ER) (High and Dobberstein, 1992) and then trans-
ported to the Golgi apparatus (Farquhar and Palade, 1981).
Transport from the ER to the Golgi is mediated by transport
vesicles (Rothman and Orci, 1992; Schekman, 1992). The ER
system is segregated into several subdomains, including the
nuclear envelope, the rough ER (rER), the smooth ER (sER),
and possibly others (Sitia and Meldolesi, 1992). The Golgi
apparatus, in general, is further differentiated into the cis,
medial, trans-Golgi and the trans-Golgi network (TGN)
(Griffiths and Simons, 1986; Hong and Tang, 1993; Rothman
and Orci, 1992; Mellman and Simons, 1992). 
Despite our general understanding of the organization of the
ER, the Golgi apparatus and the molecular mechanism of
vesicular transport, the number of membrane proteins that have
been localized to the secretory pathway (especially the Golgi
apparatus) is limited and much effort has been focused on the
identification, localization and characterization of novel
membrane proteins associated with the Golgi apparatus.
Several integral membrane proteins have been shown to be
present in the cis-Golgi, including the KDEL receptor that is
involved in retrograde transport of KDEL-containing ERluminal proteins and it is enriched in the cis/medial Golgi as
well as the intermediate compartment/ER (Tang et al., 1993;
Griffiths et al., 1994), a type I membrane protein named p53
carrying a KKXX localization motif for the ER (Schweizer et
al., 1988) that recycles between the cis-Golgi and the interme-
diate compartment/ER (Schweizer et al., 1990), p58, a rat
counterpart of p53 (Saraste et al., 1987; Saraste and Svensson,
1991), gp74 (Alcalde et al., 1994), and GIMPc (Yuan et al.,
1987). With the exception of the KDEL receptor, the functional
aspects of these proteins have not been established. So far,
none of these proteins has been used extensively for the char-
acterisation of the cis side of the Golgi due to the fact that most
of them are present in a few distinct compartments (including
the cis-Golgi), the corresponding antibody does not effectively
detect the antigen via immunoblotting or immunoprecipitating
analysis, or the antigen is not widely expressed and/or
conserved. N-acetylglucosamyltransferase I (Dunphy et al.,
1985), GP160 (Gonatas et al., 1989), and Golgi mannosidase
II (Burke et al., 1982) have been shown to be enriched in the
medial Golgi. b 1,4-galactosyltransferase is an example of
markers of the trans-Golgi (Roth and Berger, 1982). a 2,6-sia-
lyltransferase (Mellman and Simons, 1992; Roth et al., 1985;
Tang et al., 1992) and GIMPt (Yuan et al., 1987) are confined
to the TGN, although a 2,6-sialyltransferase is also present in
the trans-Golgi. TGN38/41 (Luzio et al., 1990; Reaves et al.,
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Fig. 1. mAb HFD9 detects a 28 kDa protein enriched in Golgi
membranes. Proteins (100 m g) from the total membrane (TM),
microsomal membranes (MM), and Golgi-enriched membranes
(GM), all derived from rat liver homogenate, were solubulized in
SDS sample buffer and analyzed by immunobotting with either
polyclonal antibodies against b -galactoside a 2,6-sialyltransferase
(anti-ST) (a) or mAb HFD9 (b). 1992) and mannose-6-phospate receptors (Dahms et al., 1989)
are examples of proteins that recycle between the TGN and
post-Golgi structures. It appears that much more work will be
required to gain additional insight about the protein composi-
tion of the Golgi apparatus and to reveal their functions. 
In order to understand the overall structure and function of
the Golgi apparatus, we have previously developed a protocol
to biochemically fractionate the proteins of Golgi-enriched
membranes (Subramaniam et al., 1992). One mAb (HFD9)
raised to a Golgi sub-fraction detects a novel 28 kDa integral
membrane protein (p28) enriched in the cis-Golgi. This mon-
oclonal antibody should prove to be a useful tool for the
detailed characterisation of the cis-side of the Golgi because
the antigen is widely expressed and its epitope is localised to
the cytoplasm. Furthermore, the antibody works well in
immunolabelling, immunoblotting, and immunoprecipitating
experiments.
MATERIALS AND METHODS
Materials
The human epidermoid carcinoma cell line A431, and the rat embryo
fibroblast (REF) cell lines were obtained from Dr Catherine Pallen of
the same Institute. The mouse hypothalamic cell line GT1-7 (Mellon
et al., 1990) was obtained from Dr Pamela L. Mellon (UC San Diego).
Madin-Darby canine kidney (MDCK) cell line (strain II) was from Dr
Kai Simons (EMBL). Normal rat kidney (NRK), normal rat liver
(NRL), African green monkey kidney CV1, and SV40 transformed
CV1 (Cos), Madin-Darby bovine kidney (MDBK), Chinese hamster
overy (CHO), mouse embryonic fibroblasts (NIH3T3), rat glial C6,
and monkey kidney Vero cell lines were purchased from the ATCC.
Rabbit antiserum against rat liver Golgi a -mannosidase II was a
gracious gift from Dr Kelley Moremen (University of Georgia).
Digitonin, monoclonal antibodies against b -tubulin, WGA- and
ConA-agaroses were purchased from Sigma. Jacalin-, VVL-, PNA-
and ECA-agaroses were products of Vector Labs. Rainbow 14C
molecular mass standards and 125I-Protein A were from Amersham
(UK). Sheep anti-mouse IgG conjugated to FITC and sheep anti-rabbit
IgG labelled with rhodamine were purchased from Boehringer
Mannheim Biochemicals (Germany). Unconjugated rabbit anti-mouse
IgG was obtained from Dako Corp.
Isolation of Golgi-enriched membranes
Membranes enriched for the Golgi apparatus were prepared as
described previously with minor modifications (Subramaniam et al.,
1992). Briefly, rat livers were homogenized in a 0.25 M sucrose
solution buffered with 25 mM Hepes, pH 7.3, containing 5 mM
MgCl2 and 1 mM PMSF. The homogenate was centrifuged for 20
minutes at 650 g. The post-nuclear supernatant was then centrifuged
at 150,000 g for 60 minutes to pellet the total membranes (TM). The
membranes were then resuspended in 1.25 M sucrose and overlaid
with step-gradients of buffered 1.1 M and 0.25 M sucrose. These tubes
were then spun at 28,000 rpm (140,000 g) in a SW28 rotor for 3 hours.
The Golgi layer (GM) at the interface of the 1.1 M and 0.25 M sucrose
solutions was removed, diluted and then pelleted at 150,000 g for 1
hour. The microsomal membrane (MM) pellet was also saved.
Fractionation of Golgi-enriched membranes
Golgi membranes (fraction A in Fig. 7a) were extracted with 10 mM
EGTA, 25 mM Hepes, pH 7.3, for 30 minutes on ice followed by a
150,000 g spin (30 minutes). The supernatant (fraction B in Fig. 7a)
was saved and the resulting pellet was extracted with 150 mM
Na2CO3, pH 11.5, for 30 minutes on ice and then spun as above. The
membrane pellet was then extracted with 1% sodium deoxycholate(DOC), 10 mM Tris, pH 7.4, 1 mM PMSF on ice for 30 minutes. This
suspension was spun as above. The sodium carbonate and DOC
soluble proteins were further fractionated by lectin affinity chro-
matography. The proteins were sequentially incubated with WGA-
agarose and ConA-agarose (resulting in fractions D, E and F for the
sodium carbonate extract and fractions H, I, and J for the DOC extract
in Fig. 7a). The bound proteins were eluted with 0.5 M N-acetyl D-
glucosamine or 0.5 M a -D-methyl mannopyranoside, respectively.
Unbound proteins of the DOC extract were used as the antigen source
for monoclonal antibody preparation. 
Preparation of monoclonal antibodies
Balb/C mice were injected intraperitoneally with 25-50 m g of the flow
through (fraction J in Fig. 7a) of the deoxycholate extract emulsified
with complete Freund’s adjuvant. Booster injections of the antigen in
incomplete adjuvant were administered thrice at 3 week intervals. Tail
bleeds of the mice were checked by indirect immunofluorescence for
perinuclear staining of cells. Mice with positive staining were then
injected intravenously with 10 m g of the antigen and sacrificed 4 days
later. Splenocytes of the mouse were fused with NS-1 myeloma cells.
The resulting hybridomas were screened by immunofluorescence for
perinuclear staining patterns 1-2 weeks later. One such positive
hybridoma, designated HFD9, was cloned by two consecutive limiting
dilutions. 
SDS-PAGE and immunoblot analysis
SDS-polyacrylamide gel electrophoresis (PAGE) was performed as
described before (Subramaniam et al., 1992). Proteins separated by
SDS-PAGE were electroblotted onto a nitrocellulose filter in 10 mM
3-cyclohexylamino-1-propane sulfonic acid (CAPS) (pH 11), 10%
methanol at 500 mA for 1 hour. The filter was blocked in PBS con-
taining 5% non-fat milk and 0.05% Tween (PBST) for 2 hours at room
temperature. The filter was rinsed in PBST and incubated with tissue
2407A 28 kDa cis-Golgi integral membrane protein culture supernatant or a 1:300 dilution of rabbit serum against a 2,6-
sialyltransferase (Subramaniam et al., 1992) for 1 hour followed by 3
washes in PBST. The filter was then incubated in 5 m g/ml of rabbit
anti-mouse IgG (only for tissue culture supernatant) in blocking buffer
for 1 hour, washed 3 times, and then incubated in a 1:1,000 dilution
of 125I-Protein A for 1 hour. After several washes, the filter was
exposed to X-ray film at - 70°C.Fig. 2. Golgi-like labelling for p28 was detected in many different cell li
microscopy, as described in detail in Materials and Methods, to detect p2Immunoprecipitation
Flasks of confluent MDCK cells were pulse-labelled for 30 minutes
with [35S]methionine (1 mCi/ml) followed by a 2 hour chase or no
chase. Cells were washed with PBS and then extracted with buffer
containing 1% Triton X-100 (TX-100) for 1 hour on ice. The extract
was then centrifuged at 150,000 g for 30 minutes and the pellet re-
extracted with buffered 1% DOC. After 1 hour on ice the tubes werenes. Indicated cell lines were processed for indirect immunofluorescence
8. Bar, 10 m m
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Fig. 3. (A) Colocalization of p28 with a Golgi marker. p28 colocalized well with Golgi mannosidase II in NRK cells (a,b). Like mannosidase II
(d), p28 was redistributed into ER-like labelling in NRK (c) cells by brefeldin A. Under brefeldin A treatment, mannosidase II was clearly
present in the nuclear envelope (d) while no detectable p28 was present in the nuclear envelope (c). Some vesicular labelling was observed for
p28 after brefeldin A treatment (c). (B) Significant amount of p28 colocalized with the vesicular/spotty structures marked by the KDEL
receptor after brefeldin A treatment. NRK cells were treated with brefeldin A and then processed for double-labelling with polyclonal
antibodies against the KDEL receptor (a) and mAb against p28 (b). Bar, 5 m m.
2409A 28 kDa cis-Golgi integral membrane protein centrifuged again. The TX-100 and DOC extracts were incubated with
Protein A-Sepharose which had been coated with monoclonal anti-
bodies against p28 via a ‘bridge’ of rabbit anti-mouse IgG. After a 2Fig. 4. p28 is enriched in the Golgi region. (A) Thawed cryosections of 
by a overnight chase were labelled with mAb against p28 followed by ra
particles (large arrows) label late endosomes and/or lysosomes. The 10 n
structures around the Golgi stack (G). Some labels are also evident in th
(B) Cryosections of mouse L cells were processed for immunogold labe
and vesicular-tubular elements on one side of the Golgi stack (G). Bars,hour incubation at 4°C the beads were washed extensively and then
boiled in SDS-PAGE sample buffer without b -mercaptoethanol and
dye. The preparation was diluted with extraction buffer and onceNRK cells that had internalized 16 nm gold BSA for 4 hours followed
bbit anti-mouse Ig and then Protein A gold (10 nm). The 16 nm gold
m gold particles (small arrows) are enriched in vesicular-tubular
e Golgi stack. The late endosomes/lysosomes are free of label. 
lling to detect p28. p28 labelling was enriched in cisternal (arrowheads)
 100 nm.
2410 V. N. Subramaniam and othersagain incubated with antibody-coated beads. After a further 2 hour
incubation, the beads were washed, boiled in SDS-PAGE sample
buffer and analyzed by SDS-PAGE followed by fluorography.
Indirect immunofluorescence microscopy
Cells grown to 50-80% confluency on cover slips were fixed in 3%
paraformaldehyde in PBSCM (PBS containing 1 mM CaCl2 and 1
mM MgCl2) for 30 minutes at room temperature. Cells were then
washed 3· and then permeabilized in PBSCM containing 0.1%
saponin followed by incubations with either a rabbit antiserum against
a -mannosidase II, b 1,4-galactosyltransferase and/or monoclonal anti-
bodies against p28 for 1 hour at room temperature. The cells were
washed 3· and then incubated with either sheep anti-rabbit IgG con-
jugated with rhodamine or sheep anti-mouse IgG conjugated to FITC
(or both) in fluorescence dilution buffer (Low et al., 1991) for 1 hour.
These were then washed, mounted, and viewed using a Carl Zeiss
Axiophot microscope equipped with epifluorescence optics. For the
epitope localization experiment, NRK52E cells were fixed with 3%
paraformaldehyde on ice for 30 minutes followed by extensive
washes. They were then permeabilized with 20 m g/ml digitonin in
PBSCM for 5 minutes on ice. The detergent was removed and the
coverslips were washed five times with PBSCM. In control experi-
ments these cells were then permeabilized with 0.1% saponin.
Antibody incubations were for 1 hour with either the monoclonal
antibody HFD9 and rabbit anti- b -tubulin or anti- a -mannosidase II
and HFD9. This was followed by incubations with FITC and
rhodamine-conjugated secondary antibodies. The coverslips were
mounted and viewed as described (Low et al., 1991; Subramaniam et
al., 1992).
Protease treatment of Golgi membranes
100 m g of Golgi-enriched membranes (in 0.25 M sucrose, 25 mM
Hepes, pH 7.3) was incubated at 4°C for 1 hour in the presence or
absence of trypsin (at concentrations of 1 mg/ml or 5 mg/ml) with or
without 1% Triton X-100. The reactions were stopped by the addition
of 2 mM PMSF and the samples separated by SDS-PAGE and
analyzed by immunoblot.
Lectin binding analysis
200 m g of proteins extracted from Golgi membranes were incubated
with ECA-, VVL-, PNA- and Jacalin-agarose in lectin buffer (50 mM
Tris, pH 8.0, 150 mM NaCl, 1 mM CaCl2, 2.5 mM MgCl2, 1 mM
MnCl2, 1 mM PMSF) for 1 hour at room temperature. The beads wereFig. 5. p28 is enriched in the cis-Golgi. Cryosections of SA:48 cells (whi
side of the Golgi) were processed for immunogold double-labelling to de
(arrowheads) was enriched in the opposite (the cis) side of the Golgi stac
sialyltransferase (small arrows). R, ER. Bar, 100 nm.spun down and the supernatant saved. The lectin beads were washed
three times with lectin buffer and then boiled in SDS-PAGE sample
buffer and analysed by immunoblot analysis.
Differential extraction of Golgi membranes
100 m g of Golgi membranes were extracted with either PBS, 1 M
NaCl, 2.5 M urea, 150 mM Na2CO3, pH 11.5, 100 mM NaHCO3, pH
11.0, 1% Triton X-100, 1% NP-40, or 1% DOC in 10 mM Tris, pH
7.4, for 1 hour on ice. The membrane extracts were then centrifuged
at 150,000 g for 1 hour. The supernatants and pellets were analyzed
by SDS-PAGE and immunoblotting.
Protein assay
Protein content of various fractions was determined by the BCA assay
(Pierce Chemical Co.). BSA was employed as a standard.
Immunogold labeling
Cells were removed from the dish using proteinase K and fixed
overnight with 4% paraformaldehyde. Cryosections of the fixed cells
were prepared and labelled as described previously (Griffiths, 1993;
Griffiths et al., 1994; Krijnse-Locker et al., 1994).
RESULTS AND DISCUSSION
mAb HFD9 identifies a conserved 28 kDa protein
confined to the perinuclear Golgi region in many cell
types
Golgi-enriched membranes isolated from rat liver were frac-
tionated as described previously (Subramaniam et al., 1992,
also see Fig. 7). The flow-through of DOC extract (fraction J
in Fig. 7) was used to immunize Balb/c mice. Splenocytes from
an immunized mouse were fused with NS1 myeloma cells.
Hybridomas were selected and their secreted antibodies
screened for Golgi-like staining by indirect immunofluores-
cence microscopy. One hybridoma (HFD9), of IgG1 subtype,
exhibited Golgi-like staining and was cloned by two consecu-
tive limiting dilutions. A 28 kDa protein (p28) was specifically
detected by immunoblot analysis (Fig. 1b) which was highly
enriched in the Golgi-enriched membrane fraction (GM) (lanech stably express an epitope-tagged a 2,6-sialyltransferase in the trans
tect p28 (10 nm gold) and a 2,6-sialyltransferase (5 nm gold). p28
k (G) as compared to the the trans-Golgi side (T) marked by the a 2,6-
2411A 28 kDa cis-Golgi integral membrane protein 3) as compared to the total membranes (TM) (lane 1) and
microsomal membranes (MM) (lane 2). Under the same con-
ditions (Fig. 1a), polyclonal antibodies against rat b -galacto-
side a 2,6-sialyltransferase (anti-ST) (Subramaniam et al.,Fig. 6. The epitope recognized by mAb HFD9 is exposed to the cytosol. 
digitonin followed by saponin (c-d, g-h) and then processed for indirect i
Golgi mannosidase II (a-d) or p28 and Golgi mannosidase II (e-h). Like t
under which the luminal Golgi mannosidase II is not accessible to the an
(lanes 3,4, lanes 7,8), or 5 (lanes 9,10) mg/ml in the absence or presence 
immunoblotting to detect p28 (lanes 1-4) or the 42 kDa subunit of the rat
A
B1992; Tang et al., 1992) revealed similar enrichment of ST (the
48 kDa band) in the Golgi-enriched membrane (lane 3).
Indirect immunofluorescence microscopy (Fig. 2) revealed
that p28 is confined to the perinuclear structures, typical of the(A) NRK cells were permeabilized with digitonin alone (a-b, e-f) or
mmunofluorescence microscopy to detect simultaneously tubulin and
ubulin (a), p28 was detected in cells permeabilized with digitonin (e),
tibodies (b,f). (B) Golgi membranes were treated with trypsin at 1
of TX-100 as indicated. The samples were then processed for
 liver asialoglycoprotein receptor (R1) (lanes 5-10). Bar, 10 nm.
2412 V. N. Subramaniam and othersGolgi apparatus (Louvard et al., 1982), in many different cell
types derived from diverse species. Similar labelling patterns
were also observed in NRK cells (Fig. 3A) and A431 cells
(data not shown). These results demonstrate that the epitope of
p28 recognized by mAb HFD9 is highly conserved and that
p28 is expressed at significant levels in all the cell lines
examined. The conservation and wide-spread occurrence of
p28 indicate that it may play an important role in Golgi
structure and function.
The Golgi localization of p28 was confirmed by its colocal-
ization with Golgi mannosidase II in NRK cells (Fig. 3A) and
b 1,4-galactosyltrasferase in A431 cells (data not shown). Fur-
thermore, like these two Golgi markers, treatment of cells with
brefeldin A resulted in the redistribution of the majority of p28
into vesicular-reticular ER-like structures (Fig. 3), a character-
istic of Golgi-associated proteins (Klausner et al., 1992). Inter-
estingly, some of the vesicular/spotty structures of p28 after
brefeldin A treament colocalized with the cis-Golgi-enriched
mammalian KDEL receptor (Fig. 3B) (Tang et al., 1993;
Griffiths et al., 1994). Such spotty structures have been
observed for other cis-Golgi enriched proteins, such as p53 and
p58 after brefeldin A treatment (Lippincott-Schwartz et al.,Fig. 7. Golgi membranes were biochemically fractionated (a) into
fractions A-J (b). Proteins of each fraction were processed for
immunoblot analysis to detect p28 or b -galactoside a 2,6-
sialyltransferase (ST) as indicated. p28 is mainly detected in fraction
J, while ST is mainly in fraction I.1990; Saraste and Svensson, 1991). These results suggest that
p28 may also be enriched in the cis-Golgi.
The bulk of p28 is associated with tubular-vesicular
elements of the cis-Golgi
Immunogold labelling of cryosections revealed that p28 is
enriched in the cisternal and vesicular-tubular elements around
the Golgi stack in NRK and mouse L cells (Fig. 4). To define
the precise location of p28 in the Golgi, double-immunogold
labeling was performed in SA:48 cells (kindly provided by
Tommy Nilsson, Imperial Cancer Research Fund), which were
derived from Hela cells that stably express a 2,6-silayltrans-
ferase C-terminally tagged with the P5D4 epitope of the cyto-
plasmic domain of the vesicular stomatitis virus G protein (Fig.
5). As shown, p28 is enriched in one side of the Golgi stack
opposite to that enriched in a 2,6-sialyltransferase, a trans-
Golgi/TGN marker (Roth et al., 1985; Tang et al., 1992). These
results, taken together, establish that p28 is enriched in the cis-
Golgi structures.
The epitope recognized by mAb HFD9 is exposed to
the cytosol
To examine the location of the epitope recognized by mAb
HFD9, two independent approaches were employed. When the
plasma membrane of NRK cells was selectively permeabilized
with low concentrations of digitonin (20 m g/ml), antibodies
against tubulin gave strong microtubule labelling (Fig. 6A,a).
Under identical conditions (double-labelling), antibodies
against Golgi mannosidase II failed to reveal any specific
labelling (Fig. 6A,b) due to the luminal localization of the bulk
of mannosidase II polypeptide (Moreman and Robbins, 1991).
When the digitonin-permeabilized cells were further treated
with 0.1% saponin to permeabilize internal membranes, anti-
bodies against Golgi mannosidase II revealed strong Golgi
labelling (Fig. 6A,d). These results established that when the
cells were treated with digitonin, the plasma membrane but not
the Golgi membrane was permeabilized. When cells were
treated with both digitonin and saponin, both the plasma and
Golgi membranes were permeabilized. These conditions were
used to examine the orientation of the epitope recognized by
the mAb HFD9. When cells were treated with digitonin, p28
(e) but not mannosidase II (f) was selectively detected. Both
p28 (g) and mannosidase II (h) were detected when the cells
were treated with both digitonin and saponin. These results
demonstrate that the epitope of p28 recognized by mAb HFD9
is exposed to the cytosol.Fig. 8. Golgi membranes were extracted under various conditions as
indicated. The extracted and non-extracted proteins were separated
by centrifugation into the supernatant (S) and the pellet (P),
respectively, and then analyzed by immunoblotting to detect p28.
2413A 28 kDa cis-Golgi integral membrane protein When intact (lane 3 of Fig. 6B) or TX-100 permeabilized
(lane 4) Golgi membranes were treated with trypsin, p28 could
no longer be detected by immunoblot analysis. As a control,
polyclonal antibodies against the 42 kDa (R1) subunit of
asialoglycoprotein receptor (our unpublished results) detected
a protected fragment of about 38 kDa, consistent with the
selective removal of the cytoplasmic tail of R1 by trypsin (lane
7 and 9). When the trypsin treatment was performed in the
presence of 0.1% TX-100, the 38 kDa fragment was less
protected at low concentrations of trypsin (lane 8) and was
totally degraded at a higher trypsin concentration (lane 10).
These results confirmed the cytoplasmic orientation of the p28
epitope.
p28 is a non-glycosylated integral membrane
protein
Using a previous developed protocol (Subramaniam et al.,
1992), Golgi-enriched membranes were fractionated (Fig. 7a)
into fractions A-J. Proteins from each fraction were analysed
by immunoblot analysis to detect p28 or a 2,6-sialyltransferase
(Fig. 7b). As shown, p28 was not extracted from the membrane
by either EGTA (lane 2, fraction B) or high pH (pH11.5) (lanes
3-6, fractions C-F). p28 was detected predominantly in the J
fraction (lane 10), which represents proteins in the DOC
extract that do not bind either WGA- or Con A-agarose. In
contrast, a 2,6-sialyltransferase is mainly in the Con A-binding
fraction (lane 9, fraction I) of the DOC extract. No detectable
amount of ST is present in the WGA-binding fraction (lane 8,
fraction H), suggesting that ST is poorly sialylated. TheseFig. 9. p28 in intact cells is readily extractable by TX-100. MDCK
cells were pulse-labelled with [35S]Met for 30 minutes followed by
no chase (lanes 2,3) or a 2 hour chase (lanes 4,5). Cells were
extracted with buffer containing 1% TX-100 and the extract was
separated from the cell debris by centrifugation. The cell debris was
then extracted with buffer containing 1% DOC. The TX-100 and
DOC extracts were then processed for immunoprecipitation with
mAb HFD9.results are consistent with a recent report that N-glycans of rat
liver ST are not fully processed (Colley et al., 1992). When the
Golgi extract was incubated with ECA-agarose (which binds
terminal b 1,4-linked galactose) (Lis and Sharon, 1986), p28 is
found mainly in the unbound fraction (data not shown). Since
the majority of p28 does not bind WGA-, Con A-, or ECA-
agarose, p28 is probably not N-glycosylated. This was further
confirmed by the fact that the size of the newly-labeled ER
precursor of p28 is not affected by endo H treatment (data not
shown). Similarly, p28 did not bind VVL-, Jacalin- or PNA-
agarose (data not shown), three lectins that bind various struc-
tures of O-linked glycans (Hortin, 1990; Lis and Sharon, 1986;
Tollefsen and Kornfeld, 1983), suggesting that p28 is also not
O-glycosylated. As mentioned above, p28 is not extracted by
EGTA or pH 11.5 but by DOC, suggesting that it is an integral
membrane protein. This was further confirmed by the fact that
p28 is not solubilized by PBS, 1 M NaCl, 2.5 M urea, pH 11.5
or 11, partially extracted by TX-100 (1%) or NP-40 (1%), but
effectively extracted by 1% DOC (Fig. 8). These results, taken
together, suggest that p28 is an integral membrane protein that
is probably not glycosylated.
The partial solubility of p28 by 1% TX-100 in Golgi-
enriched membranes prompted us to examine whether this is
an intrinsic property of p28 or whether this occurred during the
isolation of the Golgi membranes. To resolve this, MDCK cells
were pulse-labelled with [35S]Met for 30 minutes followed by
either a 2 hour chase (Fig. 9, lane 4-5) or without chase (lane
2-3). Cells were sequentially extracted by 1% TX-100 and 1%
DOC and the extracts were processed to immunoprecipitate
p28. The immunoprecipitates were then resolved by SDS-
PAGE and fluorography. After either a 30 minutes labelling
(lane 2-3) or 30 minutes labelling followed by a 2 hour chase
(lane 4-5), p28 was readily extracted by 1% TX-100. Similar
results were obtained when labelled cells were chased for 5
hours (data not shown). These results obtained from intact cells
suggest that p28 is an integral membrane protein which may
become less extractable by 1% TX-100 following the isolation
of the Golgi membranes. Alternatively, it is still possible that
p28 expressed in MDCK cells has different solubility by 1%
TX-100 as compared to p28 expressed in the rat liver.
Conclusion
A detailed knowledge of the protein composition of the Golgi
apparatus is fundamental to our understanding of the function of
this important organelle. For this purpose, the continuous iden-
tification and characterization of novel proteins associated with
various Golgi subcompartments will remain important. In the
present study, we have identified and biochemically character-
ized a 28 kDa integral membrane protein associated with the
Golgi apparatus by indirect immunofluorescence microscopy.
Immunogold labelling with mAb HFD9 against p28 revealed
that p28 is enriched in one side of the Golgi stack. Double-
labelling with a 2,6-sialyltransferase of the trans side of the
Golgi established that p28 is enriched in the cis-Golgi. Previous
studies have shown that p58, p53 and the KDEL receptor are
redistributed into peripheral spotty structures when cells were
treated with brefeldin A (Lippincott-Schwartz et al., 1990;
Saraste and Svensson, 1991; Tang et al., 1993), a characteristic
of proteins associated with the cis-Golgi. In the presence of this
drug, a significant amount of p28 was also redistributed into
cytoplasmic spotty structures in NRK cells that colocalize well
2414 V. N. Subramaniam and otherswith the KDEL receptor. This result is consistent with the cis-
Golgi enrichment of p28 as revealed by immunogold localiza-
tion. To our knowledge, no 28 kDa integral membrane protein
present in the Golgi apparatus has previously been described.
p28 is thus a novel integral membrane protein of the cis-Golgi.
The functional nature of the cis-Golgi structures enriched in p28
is currently unknown. It may well represent the beginning of the
Golgi apparatus. However, recent studies have shown that the
intermediate compartment, a special domain of the ER, could
extend its membrane continuity up to the first cisternae and its
associated structures of the Golgi system (Griffiths et al., 1994;
Krijnse-Locker et al., 1994). It is thus possible that p28 enriched
structures may represent the distal region of the intermediate
compartment. Consistent with this, p28 has been shown to be
enriched in the budding compartment of mouse hepatitis virus
(data not shown). Further studies involving not only p28 but also
other markers of the secretory pathway will be required to
resolve these two possibilities.
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Golgi mannosidase II. We also thank Ms Seng Hui Low, Mr Siew
Heng Wong, and Drs Paramjeet Singh and Stephen Lowe for critical
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